WNT7a was reported to induce proliferation and β-catenin-mediated signaling in ovarian cancer, whereas, in leukemic cells, WNT7a reduces proliferation and has little effect on the activation of β-catenin. Here, WNT7A is linked to ovarian carcinoma.